# Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance

> **NCT02593331** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 79 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DRUG:** BFKB8488A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02593331
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-29
- **Primary completion:** 2017-03-28
- **Final completion:** 2017-03-28
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593331, "Study to Evaluate Safety, Tolerability, and Pharmacokinetics of BFKB8488A in Otherwise Healthy Overweight and Obese Participants With Likely Insulin Resistance". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02593331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*